Sompraz%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz HP ## Overview Sompraz HP is a combination medication containing dexlansoprazole, amoxicillin, and clarithromycin, indicated for the eradication of *Helicobacter pylori* infection. Dexlansoprazole is a proton pump inhibitor (PPI) that reduces gastric acid production. Amoxicillin and clarithromycin are antibiotics used to kill *H. pylori*. ## Primary Indications * Eradication of *Helicobacter pylori* infection in patients with duodenal or gastric ulcer disease. ## Adult Dosing **Standard Regimen:** * Sompraz HP is typically taken as one packet twice daily for 10 to 14 days. * Each packet contains: * Dexlansoprazole 60 mg * Amoxicillin 1000 mg * Clarithromycin 500 mg **Administration:** * Take one packet in the morning and one packet in the evening, generally before meals. * Dissolve the contents of each packet in a small amount of water (e.g., 30 mL or 2 tablespoons) and stir well. Drink the entire mixture immediately. ## Pediatric Dosing Pediatric dosing for Sompraz HP is not established. Dosing for individual components (dexlansoprazole, amoxicillin, clarithromycin) would need to be calculated based on pediatric guidelines and patient weight, and the combination product is not intended for pediatric use. ## Dose Adjustments * **Renal Impairment:** * Dexlansoprazole: No dose adjustment is typically required. * Amoxicillin: Dose reduction may be necessary in severe renal impairment (CrCl < 30 mL/min). Consult specific amoxicillin guidelines. * Clarithromycin: Dose reduction is recommended in patients with moderate to severe renal impairment (CrCl < 30 mL/min). Typically reduce the dose by half or double the dosing interval. * **Hepatic Impairment:** * Dexlansoprazole: Use with caution; no specific dose adjustment. * Amoxicillin: No dose adjustment. * Clarithromycin: Use with caution, especially in severe hepatic impairment, as increased serum concentrations can occur. ## Contraindications * Known hypersensitivity to dexlansoprazole, amoxicillin, clarithromycin, other macrolides, or penicillins. * History of C. difficile-associated diarrhea from prior antibiotic treatment. * Concomitant use with ergotamine derivatives. * History of cholestatic jaundice or hepatic dysfunction associated with prior clarithromycin use. ## Adverse Effects Common adverse effects include diarrhea, nausea, vomiting, abdominal pain, taste disturbances, headache, rash, and fungal infections (e.g., *Candida*). Serious adverse effects can include hypersensitivity reactions, *Clostridioides difficile*-associated diarrhea (CDAD), liver enzyme elevations, and QT prolongation (clarithromycin). ## Key Drug Interactions * **Dexlansoprazole:** May decrease the absorption of drugs that require acidic gastric pH (e.g., ketoconazole, iron salts, vitamin B12). May affect the metabolism of CYP2C19 and CYP3A4 substrates. * **Amoxicillin:** May decrease the effectiveness of oral contraceptives. Probenecid may increase amoxicillin levels. * **Clarithromycin:** Potent inhibitor of CYP3A4. Significant interactions can occur with drugs metabolized by CYP3A4 (e.g., warfarin, carbamazepine, cyclosporine, simvastatin, lovastatin, colchicine, certain calcium channel blockers, certain benzodiazepines, ergotamine, cisapride, pimozide, quinidine). Increased risk of QT prolongation with other QT-prolonging agents. ## Monitoring * Monitor for signs and symptoms of *H. pylori* eradication (e.g., resolution of ulcer symptoms). * Monitor for adverse effects, especially diarrhea and hypersensitivity reactions. * Consider monitoring liver function tests and electrolytes in patients with risk factors or prolonged use. * Monitor for drug interactions, especially with clarithromycin. ## Clinical Pearls * Ensure patients complete the full 10- to 14-day course of therapy, even if symptoms improve. * Educate patients on the importance of taking the medication as prescribed, including the timing relative to meals. * Advise patients to report any severe diarrhea, rash, or other concerning symptoms immediately. * Consider the possibility of antibiotic resistance when *H. pylori* eradication fails. *** *Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete and up-to-date details before making any clinical decisions.*